Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation
Clinical trial NCT07158710 · RECRUITING
Trial details
- NCT number
- NCT07158710
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2029-05-23
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.